National Healthcare Properties, Inc.
NASDAQ:NHPAPREIT - Healthcare Facilities
-$0.05 today
- Market cap
- $714.65M
- Beta
- 0.55
- P/E (TTM)
- 0.0
- EPS (TTM)
- $0.00
- Dividend yield
- 8.01%
Volume 0.00M
Average 0.01M
NHPAP EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
National Healthcare Properties, Inc.NASDAQ: NHPAP
EBITDA · Q1 FY2026 · quarter ended Mar 2026
EBITDA dips below year-ago levels
Q1 FY2026 EBITDA of $28.21M fell 27.8% year over year, behind the +4.7% change in trailing-twelve-month EBITDA. Sequentially, it rose 23.8% from the prior quarter. Over 3 fiscal years it compounded at +23.0% a year.
Context
- EBITDA amounted to 29.5% of revenue in FY2025, up 23.2 pp from a year earlier.
- EBITDA increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether EBITDA reaches the consensus estimate from 6 analysts of $53.08M (-47.5%) for the fiscal year ending Dec 2026, a slowdown from the +552.1% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- $28.21M+23.8% QoQ
- Last fiscal yearDec 2025
- $101.08M+552.1% YoY
- LTMMar 2026
- $85.15M+4.7% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -27.8% | -1.0% | +26.8 pp |
| 1 year | +552.1% | -47.5% | -599.6 pp |
| 3-year CAGR | +23.0% | -10.7% | -33.6 pp |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA history
USD · from the income statement
- Latest · FY2025
- 101.08M USD
- Year-over-year change
- +552.1%
- 4-year CAGR
- +24.1%
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 101.08M | +552.1% |
| FY2024 | 2024-12-31 | (22.36M) | -129.1% |
| FY2023 | 2023-12-31 | 76.87M | +41.4% |
| FY2022 | 2022-12-31 | 54.38M | +27.7% |
| FY2021 | 2021-12-31 | 42.59M | — |
EBITDA vs competitors
How NHPAP compares with its peers on the latest reported figures
- NHPAP's LTM Mar 2026 EBITDA of $85.15M is the 3rd highest of the 9 companies compared; the peer median is $64.29M.
- Its year-over-year change of +4.7% is the 4th highest of 9, against a peer median of -17.5%.
- EBITDA amounts to 24.9% of revenue for NHPAP, versus a peer median of 61.3%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $171.31M | -28.3% | — | 61.0% | |
| LTM Mar 2026 | $132.24M | +56.0% | +27.9% | 85.4% | |
NHPAPNational Healthcare Properties, Inc. | LTM Mar 2026 | $85.15M | +4.7% | +23.0% | 24.9% |
NHPBPNational Healthcare Properties, Inc. | LTM Mar 2026 | $73.51M | +495.0% | +15.1% | 21.5% |
| LTM Mar 2026 | $64.62M | -6.7% | +5.0% | 43.5% | |
| LTM Mar 2026 | $63.96M | -46.0% | +4.9% | 38.6% | |
| LTM Mar 2026 | $61.88M | +33.9% | +27.2% | 61.6% | |
| LTM Mar 2026 | -$230.26M | -166.3% | -29.1% | 131.2% | |
| LTM Mar 2026 | -$446.03M | -1164.6% | — | 120.1% | |
| Peer median (excluding NHPAP) | $64.29M | -17.5% | +10.0% | 61.3% | |
Competitors are the stored peer set for NHPAP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 329.36M | 335.85M | 345.93M | 353.79M | 342.28M |
| Cost of Revenue | 205.81M | 213.44M | 217.79M | 221.15M | 218.9M |
| Gross Profit | 123.54M | 122.4M | 128.13M | 132.65M | 123.38M |
| Gross Margin | 37.5% | 36.4% | 37.0% | 37.5% | 36.0% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 16.83M | 17.29M | 18.93M | 22.74M | 24.19M |
| Operating Expenses | 160.98M | 153.94M | 132.87M | 256.19M | 120.08M |
| Depreciation & Amortization | 79.73M | 82.06M | 82.87M | 84.07M | 80.15M |
| EBITDA | 42.59M | 54.38M | 76.87M | (22.36M) | 101.08M |
| EBITDA Margin | 12.9% | 16.2% | 22.2% | -6.3% | 29.5% |
| Operating Income | (37.44M) | (31.54M) | (4.74M) | (123.54M) | 3.3M |
| Operating Margin | -11.4% | -9.4% | -1.4% | -34.9% | 1.0% |
| Interest Income | 61K | 27K | 734K | 1.05M | 272K |
| Interest Expense | 47.9M | 51.74M | 66.08M | 69.45M | 71.65M |
| Other Income / Expenses | (47.8M) | (47.88M) | (67.34M) | (66.46M) | (60.82M) |
| Income Before Tax | (85.24M) | (79.42M) | (72.08M) | (190M) | (57.52M) |
| Pre-Tax Margin | -25.9% | -23.6% | -20.8% | -53.7% | -16.8% |
| Income Tax Expense | 203K | 201K | 303K | 262K | 161K |
| Net Income | (85.18M) | (79.49M) | (72.3M) | (189.7M) | (57.62M) |
| Net Margin | -25.9% | -23.7% | -20.9% | -53.6% | -16.8% |
| EPS (Basic) | (3.29) | (3.30) | (3.04) | (7.19) | (2.51) |
| EPS (Diluted) | (3.29) | (3.30) | (3.04) | (7.19) | (2.51) |
| Weighted Avg Shares | 25.88M | 24.08M | 23.75M | 26.37M | 22.95M |
| Weighted Avg Shares (Diluted) | 28.24M | 28.26M | 28.28M | 28.29M | 28.3M |
National Healthcare Properties, Inc.
NASDAQ:NHPAP
Intrinsic Alpha fair value
Locked
Current Price
$25.24
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.